why am i stalling on tirzepatide How to Break a Stall Tirzepatide: Evidence-Based Strategies Why Weight Loss Plateaus on

In the most recent published trial, about 10 per cent of people taking tirzepatide dropped out of the study because of such problems, compared to about 2 per cent of people taking a placebo

doi: 10.1186/s13567-020-00755-3 [DOI] [PMC free article] [PubMed] [Google Scholar] 254

Patient discontinuation occurred in 12.5% (6 weeks) and 17.8% (16 weeks) of patients due to gastrointestinal, vascular, or cardiac adverse effects, respectively [54]

Reference: Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial - ( Source-Medindia

This initial phase establishes tolerance and confirms the medication is working for appetite control

A proud graduate of the University of Mississippi (Ole Miss) School of Pharmacy, she earned both her Bachelor of Science and Doctor of Pharmacy degrees through an accelerated 6-year program